WednesdayJul 15, 2026 4:20 pm

420 with CNW — Study Shows Restless Legs Syndrome Patients Benefit from Medical Marijuana

A new study suggests that marijuana-based treatment may provide lasting relief for people living with restless legs syndrome (RLS).  RLS causes an overwhelming urge to move the legs and disrupts sleep. The disorder affects an estimated 7 to 12 percent of adults in North America and Europe and is more frequent among those with multiple sclerosis.  For many years, dopamine agonists have been considered the primary therapy for RLS. More recently, however, research has shifted toward gabapentinoids as a preferred option. Since cannabinoids and gabapentinoids influence similar biological pathways involving certain amino acids linked to the condition, researchers wanted to determine whether cannabis compounds could also ease symptoms.  The open-label study enrolled adults with long-term RLS whose symptoms had persisted despite…

Continue Reading

TuesdayJul 14, 2026 4:20 pm

420 with CNW — Wyoming Snubs Federal Marijuana Reclassification, Retains Marijuana Under Schedule I

Wyoming will retain cannabis and related products under the state’s most restrictive controlled substance category, declining to follow a recent federal change that shifted some cannabis-based products into a lower category. The state Attorney General’s Office announced that Wyoming’s Commissioner of Drugs and Substances Control issued a final order opposing the federal reclassification. The federal action stemmed from a rule released by the DOJ on April 28. Under that rule, cannabis contained in products approved by the FDA, along with products associated with state-regulated medical cannabis programs, was moved to Schedule III under the CSA. The change also covered certain…

Continue Reading

WednesdayJul 08, 2026 4:20 pm

420 with CNW — DEA Opens Rescheduling Hearing by Expressing Support for Reclassification

Federal officials used the opening day of a closely watched administrative hearing on June 29 to reaffirm their support for a proposal that would move marijuana to Schedule 3 under federal law. Speaking at the DEA’s headquarters in Arlington, Virginia, James J. Schwartz, an attorney with the agency’s Office of Chief Counsel, said the federal government continues to back the proposed change. He told the administrative law judge overseeing the proceedings that the government would present expert testimony to support the recommendation to reclassify marijuana under the Controlled Substances Act. Schwartz said the government’s role in the hearing is to…

Continue Reading

TuesdayJun 09, 2026 4:20 pm

420 with CNW — Kentucky Governor Broadens List of MMJ Qualifying Conditions

Kentucky Governor Andy Beshear has moved to broaden access to the state’s medical cannabis program, signing an executive order that expands the range of medical conditions eligible for treatment and renewing his call for wider marijuana reform.  Speaking at a news conference last week, Beshear said the action is intended to provide greater clarity around Kentucky’s existing medical cannabis law. According to the governor, the current statute already allows marijuana to be recommended for symptoms such as nausea and chronic pain.  His order makes it clear that patients diagnosed with illnesses commonly associated with those symptoms may also qualify for…

Continue Reading

MondayJun 01, 2026 4:20 pm

420 with CNW — DEA Prepares for Hearings on Federal Marijuana Rescheduling

Federal regulators are moving closer to a key decision on cannabis policy as the DEA prepares to hold a hearing in June on the reclassification of marijuana under national law. The proceedings have already attracted interest from groups on both sides of the legalization debate, highlighting the continuing divide over cannabis reform in the U.S. Advocacy organizations supporting legalization, including NORML, have officially signaled plans to join the hearing. At the same time, anti-legalization voices such as Smart Approaches to Marijuana are also expected to take part. The event represents another important stage in the long-running effort to reconsider marijuana’s…

Continue Reading

FridayMay 29, 2026 4:20 pm

420 with CNW — Missouri Regulators Prepare Final Marijuana License Lottery

Missouri cannabis regulators are preparing for a statewide outreach effort ahead of the final lottery that will distribute 77 microbusiness marijuana permits, with officials hoping recent policy changes will strengthen oversight and reduce problems that have troubled earlier rounds.  Throughout June, Missouri’s marijuana regulatory division chief equity officer Lesley Turek plans to host informational sessions in St. Louis, Kansas City, and Jefferson City along with five virtual events. The meetings are intended to guide prospective applicants through the process, explain eligibility standards and answer questions before submissions begin later this summer.  A key focus of the presentations will be new regulations scheduled to take effect at…

Continue Reading

FridayMay 15, 2026 4:20 pm

420 with CNW — Study Suggests Marijuana Could Boost Weight Loss, Support Metabolic Health

A new preclinical investigation from the University of California, Riverside, is offering fresh insight into a puzzling trend researchers have observed for years: people who regularly use cannabis often show lower body weight and a smaller likelihood of developing type 2 diabetes, even though marijuana is widely known to stimulate hunger. Led by Professor Nicholas V. DiPatrizio of the UCR School of Medicine, the research explored why long-term marijuana users frequently show healthier metabolic patterns than non-users, despite the drug’s reputation for triggering cravings and overeating. The study focused on how different cannabis compounds influence body weight and blood sugar…

Continue Reading

ThursdayMay 07, 2026 4:20 pm

420 with CNW — Marijuana Reclassification Eases Some Industry Hurdles

Cannabis rescheduling in the U.S. could reshape scientific research and parts of the industry, though key questions remain about how the change will be carried out.  Under a final rule issued by the Office of the Attorney General, federally approved drug products containing marijuana would be placed in Schedule III of the CSA. This represents a significant change from the current Schedule I status, a category reserved for substances considered highly dangerous and lacking accepted medical use. Moving cannabis into Schedule III places it alongside drugs such as ketamine and codeine, signaling recognition of its therapeutic potential.  Researchers say the adjustment could ease some of the strict requirements that have long complicated cannabis studies. Daniele Piomelli, a professor of anatomy and…

Continue Reading

TuesdayApr 28, 2026 4:20 pm

420 with CNW — US DOJ Moves Some Marijuana Products to Schedule III

The Justice Department (DOJ) has rescheduled certain marijuana products, signaling a notable policy shift after decades of strict federal control. Acting AG Todd Blanche announced that cannabis products approved by the FDA or authorized under state medical cannabis programs will be moved from Schedule I to Schedule III. This adjustment places them alongside medications such as codeine-based pain relievers, reflecting a lower perceived risk and recognized medical use. Blanche also directed officials to begin a formal review that could lead to broader changes, including the possible reclassification of cannabis in its entirety. A public hearing has been scheduled for June…

Continue Reading

MondayApr 27, 2026 4:20 pm

420 with CNW — Illinois Disburses $32M to Cannabis Social Equity Firms

Illinois has taken another step in its effort to promote fairness in the legal cannabis market, issuing $31.8 million in loans to businesses identified under its social equity program. State officials confirmed that 95 companies received funding in this latest round, with individual loan amounts between $50,000 and $750,000. The loans come with favorable terms. Borrowers will not pay interest for the first 18 months, and no payments are required during that period. In addition, companies may be eligible to have the full amount forgiven if they meet certain conditions tied to how the funds are used. Lieutenant Governor Juliana…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000